Format

Send to

Choose Destination
J Clin Invest. 2000 Apr;105(8):1027-30.

Use of preferentially replicating bacteria for the treatment of cancer.

Author information

1
Vion Pharmaceuticals Inc., New Haven, Connecticut 06511, USA. msznol@vionpharm.com
PMID:
10772643
PMCID:
PMC300839
DOI:
10.1172/JCI9818
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for American Society for Clinical Investigation Icon for PubMed Central
Loading ...
Support Center